BC
BriaCell Therapeutics Corp. Warrant
BCTXZ · NASDAQ
$0.20 +31.27% (+$0.05)
1M +79.00%
Market Cap $370.9K
P/E Ratio -
Div. Yield -
ROE 147.92%
Bulios Fair Price
$0.23
16.8% upside
Current Price
$0.2
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BCTXZ is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.02x
EV/FFO N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 20.21%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 147.92%
ROA 113.23%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 7.07x
Int. coverage -1,066.21x
Debt/Equity 0.00x
Stability
22 /100
Unstable EPS volatility 61.04%
Profitable years 0
Beta 1.54x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BCTXZ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
William V. Williams
Employees
16
Headquarters
West Vancouver